Company

Company

IBI is an innovative hi-tech Swiss biomedical company focused on research, development and production of medical devices for tissue engineering and regenerative medicine: substitutes, grafts, 3D matrixes and 2D scaffolds.
IBI believes that regenerative medicine and tissue engineering represent the future for health.
IBI has strong competencies and core skills in processing materials for biomedical applications, used to develop proprietary technologies to build its new and innovative products.
IBI pays extreme attention to safety and quality: IBI is ISO13485 certified.

Company Info

Industrie Biomediche Insubri SA is a Swiss Company established under the Swiss Federal Law.

Headquarters:
Via Cantonale 67
CH-6805 Mezzovico-Vira (Ticino)
Switzerland

VAT code: CHE-112.388.119 IVA
Registration number at the Chamber of Commerce of the Canton Ticino: CH-514.3.029.225-5

Swiss Company Register Identification Number: CHE-112.388.119

To contact us click here!

IBI history at a Glance

2008

Feb/26
IBI is established as a privately owned company, under the Swiss Federal Laws.

Sept
IBI establishes in Mezzovico (Ticino, Switzerland) its Headquarter and Laboratories; IBI establishes its production at Micro-Sphere S.A., in a cGMP certified environment.

2009

Mar
IBI is among partners of the Italian/Swiss InterReg project “Clu.B.”, financed under the patronage of the European Commission by the Italian Regione Lombardia, the Swiss Federal Government and the Ticino Economic Development Office.

Jul
IBI starts selling SmartBone for lab use in cell therapies development for bone regeneration.

2010

Jan
Phoenix|x-ray (a GE company) runs innovative microCT scans on SmartBone.

2011

Jun
IBI welcomes Gianfranco Colomba as its C.E.O.

Jul
IBI opens its European Branch.

Oct
IBI obtains the approval for clinical studies on SmartBone.

2012

Feb
Agire Invest SA, the Development Agency of the Ministry of Economics of the Canton Ticino, joins IBI shareholders entering into equity as an Investor.

May
IBI secures a second investment round from Fondazione “Filippo Serpero”.

Jun
IBI obtains ISO 13485 and ISO 9001 certifications and its SmartBone obtains the CE mark for human use!

2014

The Compagnie Financiere St. Exupéry SA has become one of IBI’s shareholders and has expressed Dr. Claudio Girardi as director and vice-president.

Subscribe to our newsletter